GSK treatment could suppress the number of TRAP-positive OCs in tibial bone which was consistent with in vitro results, while OVX-mediated oxidative stress, characterized by redox imbalance, could lead to osteopenia and further to osteoporosis [58]. This evidence concerns the gene ACP5 and Osteopenia.